Abstract:BackgroundHepatitis B virus (HBV) infection is a crucial risk factor for hepatocellular carcinoma (HCC). However, its underlying mechanism remains understudied.MethodsMicroarray analysis was conducted to compare the genes and miRNAs in liver tissue from HBV-positive and HBV-negative HCC patients. Biological functions of these biomarkers in HBV-related HCC were validated via in vitro and in vivo experiments. Furthermore, we investigated the effect of HBV on the proliferation and migration of tumor cells in HBV-positive HCC tissue. Bioinformatics analysis was then performed to validate the clinical value of the biomarkers in a large HCC cohort.ResultsWe found that a gene, MINPP1 from the glycolytic bypass metabolic pathway, has an important biological function in the development of HBV-positive HCC. MINPP1 is down-regulated in HBV-positive HCC and could inhibit the proliferation and migration of the tumor cells. Meanwhile, miRNA-30b-5p was found to be a stimulator for the proliferation of tumor cell through glycolytic bypass in HBV-positive HCC. More importantly, miRNA-30b-5p could significantly downregulate MINPP1 expression. Metabolic experiments showed that the miRNA-30b-5p/MINPP1 axis is able to accelerate the conversion of glucose to lactate and 2,3-bisphosphoglycerate (2,3-BPG). In the HBV-negative HCC cells, miRNA-30b-5p/MINPP1 could not regulate the glycolytic bypass to promote the tumorigenesis. However, once HBV was introduced into these cells, miRNA-30b-5p/MINPP1 significantly enhanced the proliferation, migration of tumor cells, and promoted the glycolytic bypass. We further revealed that HBV infection promoted the expression of miRNA-30b-5p through the interaction of HBV protein P (HBp) with FOXO3. Bioinformatics analysis on a large cohort dataset showed that high expression of MINPP1 was associated with favorable survival of HBV-positive HCC patients, which could lead to a slower progress of this disease.ConclusionOur study found that the HBp/FOXO3/miRNA-30b-5p/MINPP1 axis contributes to the development of HBV-positive HCC cells through the glycolytic bypass. We also presented miRNA-30b-5p/MINPP1 as a novel biomarker for HBV-positive HCC early diagnosis and a potential pharmaceutical target for antitumor therapy.

Hepatitis B Virus X Protein Promotes Tumor Glycolysis by Downregulating Lncrna OIP5-AS1/HKDC1 in HCC

Hepatitis B Virus P Protein Initiates Glycolytic Bypass in HBV-related Hepatocellular Carcinoma Via a FOXO3/miRNA-30b-5p/MINPP1 Axis

Hepatitis B virus X protein inhibits autophagic degradation by impairing lysosomal maturation.

Hepatitis B virus X protein promotes hepatoma cell invasion and metastasis by stabilizing Snail protein

HBV Rewires Liver Cancer Signaling by Altering PP2A Complexes

HBx regulates fatty acid oxidation to promote hepatocellular carcinoma survival during metabolic stress.

C-terminal truncated HBx initiates hepatocarcinogenesis by downregulating TXNIP and reprogramming glucose metabolism

Anti-oncogene PTPN13 inactivation by hepatitis B virus X protein counteracts IGF2BP1 to promote hepatocellular carcinoma progression

The Oncoprotein HBXIP Suppresses Gluconeogenesis Through Modulating PCK1 to Enhance the Growth of Hepatoma Cells

Hepatitis B virus X protein inhibits apoptosis by modulating endoplasmic reticulum stress response.

BNIP3L-Dependent Mitophagy Promotes HBx-Induced Cancer Stemness of Hepatocellular Carcinoma Cells via Glycolysis Metabolism Reprogramming

Hepatitis B virus X protein represses expression of tumor suppressor PTPN18 in hepatocellular carcinoma

Hepatitis B Virus X Protein in the Proliferation of Hepatocellular Carcinoma Cells

HBV HBx-Downregulated lncRNA LINC01010 Attenuates Cell Proliferation by Interacting with Vimentin

The role of hepatitis B virus X protein in regulation of hypoxia inducible factor-1αand the underlying mechanisms in hepatocellular carcinoma

Hepatitis B Virus X Protein Amplifies TGF-β Promotion on HCC Motility Through Down-Regulating PPM1a

Hepatitis B Virus X Protein Upregulates Oncogene Rab18 to Result in the Dysregulation of Lipogenesis and Proliferation of Hepatoma Cells.

Elevation of Highly Up-regulated in Liver Cancer (HULC) by Hepatitis B Virus X Protein Promotes Hepatoma Cell Proliferation Via Down-regulating P18

Hepatitis B Virus X Protein Promotes P3 Transcript Expression of the Insulin‐like Growth Factor 2 Gene Via Inducing Hypomethylation of P3 Promoter in Hepatocellular Carcinoma

HBx-upregulated lncRNA UCA1 promotes cell growth and tumorigenesis by recruiting EZH2 and repressing p27Kip1/CDK2 signaling

Retraction Note: HBx/ERα Complex-Mediated LINC01352 Downregulation Promotes HBV-related Hepatocellular Carcinoma Via the Mir-135B-apc Axis.